Identifying the risk factors for late-stage head and neck cancer

References

• Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol.37(1), 94–98 (2001).
   PubMed Web of Science ®Google Scholar
• Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J. Clin.55(4), 242–258; quiz 261–242, 264 (2005).
   PubMed Web of Science ®Google Scholar
• Brockstein B, Haraf DJ, Rademaker AW et al. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann. Oncol.15(8), 1179–1186 (2004).
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts & Figures 2011. American Cancer Society (2011).
   Google Scholar
• Hashibe M, Brennan P, Benhamou S et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J. Natl Cancer Inst.99(10), 777–789 (2007).
   PubMed Web of Science ®Google Scholar
• Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet363(9420), 1488–1489 (2004).
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med.363(1), 24–35 (2010).
   PubMed Web of Science ®Google Scholar
• Weinberger PMYZ, Haffty BG, Kowalski D et al. Molecular classification identifies a subset of human papillomavirus – associated oropharyngeal cancers with favorable prognosis. J. Clin. Oncol.24(5), 736–747 (2006).
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst.100(4), 261–269 (2008).
   PubMed Web of Science ®Google Scholar
• Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch. Otolaryngol Head Neck Surg.124(9), 951–962 (1998).
   PubMedGoogle Scholar
• Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev.22(1), 25–38 (2003).
   PubMed Web of Science ®Google Scholar
• Settle K, Posner MR, Schumaker LM et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev. Res. (Phila., PA)2(9), 776–781 (2009).
   PubMed Web of Science ®Google Scholar
• Siegel R WE, Brawley O, Jemal A Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin.61(4), 212–236 (2011).
   PubMed Web of Science ®Google Scholar
• Kosary CLRL, Miller BA, Hankey BF, Harras A, Edwards BK. SEER Cancer Statistics Review, 1973–1992: Tables and Graphs. National Cancer Institue; NIH Publicaton, Bethesda, MD, USA, 96–2789 (1995).
   Google Scholar
• Stephen JK CK, Shah V, Havard S et al. DNA hypermethylation markers of poor outcome in laryngeal cancer. Clin. Epigenetics1, 61–69 (2010).
   PubMedGoogle Scholar
• Torres JB, Kittles RA. The relationship between ‘race’ and genetics in biomedical research. Curr. Hypertens. Rep.9(3), 196–201 (2007).
   PubMed Web of Science ®Google Scholar
• Worsham MJ, Divine G, Kittles RA. Race as a social construct in head and neck cancer outcomes. Otolaryngol. Head Neck Surg.144(3), 381–389 (2011).
   PubMed Web of Science ®Google Scholar
• Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol.11(8), 781–789 (2010).
   PubMed Web of Science ®Google Scholar
• Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin. Med. Diagn.4(1), 53–65 (2010).
   PubMedGoogle Scholar
• Rubin Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer78(6), 1284–1292 (1996).
   PubMed Web of Science ®Google Scholar
• Tabor MP, Brakenhoff RH, van Houten VM et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin. Cancer Res.7(6), 1523–1532 (2001).
   PubMed Web of Science ®Google Scholar
• Partridge M, Emilion G, Pateromichelakis S, A’Hern R, Phillips E, Langdon J. Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol.34(2), 77–83 (1998).
   PubMed Web of Science ®Google Scholar
• Nemunaitis J, Nemunaitis J. Head and neck cancer: response to p53-based therapeutics. Head Neck33(1), 131–134 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang HS, Postigo AA, Dean DC. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFβ, and contact inhibition. Cell97(1), 53–61 (1999).
   PubMed Web of Science ®Google Scholar
• Worsham MJ, Chen KM, Tiwari N et al. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg.132(4), 409–415 (2006).
   PubMedGoogle Scholar
• Yarbrough WG. The ARF-p16 gene locus in carcinogenesis and therapy of head and neck squamous cell carcinoma. Laryngoscope112(12), 2114–2128 (2002).
   PubMed Web of Science ®Google Scholar
• Bova RJ, Quinn DI, Nankervis JS et al. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin. Cancer Res.5(10), 2810–2819 (1999).
   PubMed Web of Science ®Google Scholar
• Weinberger PM, Yu Z, Haffty BG et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin. Cancer Res.10(17), 5684–5691 (2004).
   PubMed Web of Science ®Google Scholar
• Smeets SJ, Hesselink AT, Speel EJ et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer121(11), 2465–2472 (2007).
   PubMed Web of Science ®Google Scholar
• Baylin SB. DNA methylation and gene silencing in cancer. Nat. Clin. Pract. Oncol.2(Suppl. 1), S4–S11 (2005).
   PubMedGoogle Scholar
• Chen K, Sawhney R, Khan M et al. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg.133(11), 1131–1138 (2007).
   PubMedGoogle Scholar
• Stephen JK, Symal M, Chen KM et al. Molecular characterization of late stomal recurrence following total laryngectomy. Oncol. Rep.25(3), 669–676 (2011).
   PubMed Web of Science ®Google Scholar
• Worsham MJLM, Stephen J, Chen KM, Harvard S, Shah V, Schweitzer VP. Molecular modeling of HNC diagnosis and prognosis. Presented at: AHNS 2010 Research Workshop on Biology, Prevention & Treatment of Head & Neck Cancer. VA, USA, 28–30 October 2010.
   Google Scholar
• Chen AY, Schrag NM, Halpern M, Stewart A, Ward EM. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? Arch. Otolaryngol. Head Neck Surg.133(8), 784–790 (2007).
   PubMedGoogle Scholar